Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))

Xuan Zhang; Shichun Lun; Yu Xin Li; Wei Zhang; Ruo Yi Zhou; Ting Liu; Fan Yang; Jie Tang; William R. Bishai; Li Fang Yu

doi:10.1016/j.ejmech.2025.117239

Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))

Xuan Zhang
, Shichun Lun
, Yu Xin Li
, Wei Zhang
, Ruo Yi Zhou
, Ting Liu
, Fan Yang
, Jie Tang
, William R. Bishai^*
, Li Fang Yu^*

^*Corresponding author for this work

School of Chemistry and Molecular Engineering

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

The authors regret the groups R1-R3 in Tables 2–3 are misplaced in the current paper online. Correct forms are listed below. [Table presented] [Table presented] The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	117239
Journal	European Journal of Medicinal Chemistry
Volume	285
DOIs	https://doi.org/10.1016/j.ejmech.2025.117239
State	Published - 5 Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejmech.2025.117239

Fingerprint

Dive into the research topics of 'Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))'. Together they form a unique fingerprint.

Cite this

Zhang, X., Lun, S., Li, Y. X., Zhang, W., Zhou, R. Y., Liu, T., Yang, F., Tang, J., Bishai, W. R., & Yu, L. F. (2025). Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148)). European Journal of Medicinal Chemistry, 285, Article 117239. https://doi.org/10.1016/j.ejmech.2025.117239

Zhang, Xuan ; Lun, Shichun ; Li, Yu Xin et al. / Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148)). In: European Journal of Medicinal Chemistry. 2025 ; Vol. 285.

@article{13dc6238c9a74d60a9b3b4bea2049a73,

title = "Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))",

abstract = "The authors regret the groups R1-R3 in Tables 2–3 are misplaced in the current paper online. Correct forms are listed below. [Table presented] [Table presented] The authors would like to apologise for any inconvenience caused.",

author = "Xuan Zhang and Shichun Lun and Li, \{Yu Xin\} and Wei Zhang and Zhou, \{Ruo Yi\} and Ting Liu and Fan Yang and Jie Tang and Bishai, \{William R.\} and Yu, \{Li Fang\}",

note = "Publisher Copyright: {\textcopyright} 2025 Elsevier Masson SAS",

year = "2025",

month = mar,

day = "5",

doi = "10.1016/j.ejmech.2025.117239",

language = "英语",

volume = "285",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson s.r.l.",

}

Zhang, X, Lun, S, Li, YX, Zhang, W, Zhou, RY, Liu, T, Yang, F, Tang, J, Bishai, WR & Yu, LF 2025, 'Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))', European Journal of Medicinal Chemistry, vol. 285, 117239. https://doi.org/10.1016/j.ejmech.2025.117239

Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148)). / Zhang, Xuan; Lun, Shichun; Li, Yu Xin et al.
In: European Journal of Medicinal Chemistry, Vol. 285, 117239, 05.03.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))

AU - Zhang, Xuan

AU - Lun, Shichun

AU - Li, Yu Xin

AU - Zhang, Wei

AU - Zhou, Ruo Yi

AU - Liu, Ting

AU - Yang, Fan

AU - Tang, Jie

AU - Bishai, William R.

AU - Yu, Li Fang

PY - 2025/3/5

Y1 - 2025/3/5

N2 - The authors regret the groups R1-R3 in Tables 2–3 are misplaced in the current paper online. Correct forms are listed below. [Table presented] [Table presented] The authors would like to apologise for any inconvenience caused.

AB - The authors regret the groups R1-R3 in Tables 2–3 are misplaced in the current paper online. Correct forms are listed below. [Table presented] [Table presented] The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85214508479

U2 - 10.1016/j.ejmech.2025.117239

DO - 10.1016/j.ejmech.2025.117239

M3 - 评论/辩论

C2 - 39779391

AN - SCOPUS:85214508479

SN - 0223-5234

VL - 285

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

M1 - 117239

ER -

Zhang X, Lun S, Li YX, Zhang W, Zhou RY, Liu T et al. Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148)). European Journal of Medicinal Chemistry. 2025 Mar 5;285:117239. doi: 10.1016/j.ejmech.2025.117239

Corrigendum to “Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis” [Europ. J. Med. Chem. 283 (2025) 117148] (European Journal of Medicinal Chemistry (2025) 283, (S0223523424010304), (10.1016/j.ejmech.2024.117148))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this